A
$ Value
$0
Shares
168,000
Price
$0
Filed
Sep 8
Insider
Name
Oki Mark K
Title
Chief Financial Officer
CIK
0001491847
Roles
Officer
Transaction Details
Transaction Date
2025-09-04
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
—
Footnotes
Represents performance restricted stock units ("PRSUs") previously reported on December 9, 2024 that were earned by the Reporting Person upon the achievement of certain performance criteria as certified by the Compensation Committee of the Issuer's Board of Directors. | Each PRSU represents a contingent right to receive one share of the issuer's common stock at settlement. | Pursuant to the terms of the award agreement governing the PRSU, the total number of shares underlying the PRSU vest on the achievement of one of certain milestones.
Filing Info
Oki Mark K's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-01-28 | ACHV | A | $0 |
| 2025-09-18 | ACHV | M | $0 |
| 2025-09-18 | ACHV | ▼ | $146K |
| 2025-09-18 | ACHV | M | $0 |
| 2025-09-04 | ACHV | A | $0 |
Other Insiders at ACHV (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Oki Mark K
Chief Financial Officer
|
— | — | 2026-01-28 |
|
Stewart Richard Alistair
Chief Executive Officer
|
— | — | 2026-01-28 |
|
Goldberg Andrew D.
CEO and President
|
— | — | 2026-04-18 |
|
Wan Jerry
Principal Accounting Officer
|
— | — | 2026-01-28 |
|
Xinos Jaime
Chief Commercial Officer
|
— | — | 2026-01-28 |
|
Donnelly Craig
Chief Operations Officer
|
— | — | 2026-01-28 |
|
Rubinstein Mark Lawrence
Chief Medical Officer
|
— | — | 2026-01-28 |